Improving Medication Adherence in ADHD Adolescents
Status: | Terminated |
---|---|
Conditions: | Psychiatric, ADHD |
Therapuetic Areas: | Psychiatry / Psychology, Other |
Healthy: | No |
Age Range: | 12 - 16 |
Updated: | 2/21/2018 |
Start Date: | September 2015 |
End Date: | June 2016 |
Investigates whether a family-based intervention for adolescents with Attention Deficit
Hyperactivity Disorder (ADHD) will improve adherence to prescribed medication regimen in
adolescents with history of medication nonadherence.
Hyperactivity Disorder (ADHD) will improve adherence to prescribed medication regimen in
adolescents with history of medication nonadherence.
We will evaluate a dual component family-based intervention for adolescents with ADHD to
improve medication adherence (Supporting Teen Adherence and Responsibility; STAR). STAR pairs
Motivational Interviewing with parent-teen behavioral contracting. In the proposed study,
adolescents with ADHD and a history of chronic nonadherence to their ADHD medication will be
randomly assigned to medication alone (medication as usual: MAU) or MAU+STAR. They will be
treated for 6 months with a 12 month maintenance period and 12 month followup. All
interventions will occur at the offices of participants primary care physicians.
improve medication adherence (Supporting Teen Adherence and Responsibility; STAR). STAR pairs
Motivational Interviewing with parent-teen behavioral contracting. In the proposed study,
adolescents with ADHD and a history of chronic nonadherence to their ADHD medication will be
randomly assigned to medication alone (medication as usual: MAU) or MAU+STAR. They will be
treated for 6 months with a 12 month maintenance period and 12 month followup. All
interventions will occur at the offices of participants primary care physicians.
Inclusion Criteria:
- Diagnosis of ADHD; currently prescribed an FDA-approved medication for ADHD, history
of medication nonadherence (taking less than 60% of prescribed doses); full scale
Intelligence Quotient >80, no current language delay and/or had no language delays
before age 3.
Exclusion Criteria:
- active medical conditions that could be worsened by stimulants (seizures, arrhythmias,
hypertension) unless patient has clearance from primary specialist taking care of
existing condition, pregnancy, Bipolar Disorder, schizophrenia, and/or other psychotic
disorders, and diagnosis of current substance abuse or dependence (except nicotine),
current psychotropic medication for conditions other than ADHD.
We found this trial at
1
site
Miami, Florida 33199
Principal Investigator: William E Pelham, Ph.D.
Phone: 305-348-0477
Click here to add this to my saved trials